Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes von Rutkowski, P, Bylina, E, Wozniak, A, Nowecki, Z.I, Osuch, C, Matlok, M, Świtaj, T, Michej, W, Wroński, M, Głuszek, S, Kroc, J, Nasierowska-Guttmejer, A, Joensuu, H

Volltext

The analysis of the outcomes and factors related to iliac–obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biops... von Zdzienicki, M, Rutkowski, P, Nowecki, Z.I, van Akkooi, A.C.J, Michej, W, Dziewirski, W, Świtaj, T, Pieńkowski, A, Sałamacha, M, Bylina, E, Eggermont, A.M.M

Volltext

72. The long-term results of sentinel node biopsy with triple-technique in cutaneous melanoma von Zdzienicki, M, Szydlowski, K, Salamacha, M, Goryn, T, Mitrega-Korab, B, Pienkowski, A, Nowecki, Z.I, Dziewirski, W, Rutkowski, P

Volltext

Lapatinib and Capecitabine in the Treatment of Her2-Positive Breast Cancer with Brain Metastases von Dubianski, R., Brewczynska, E., Lemanska, I., Szombara, E., Nowecki, Z.I.

Volltext

398PLAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES von Dubianski, R., Brewczynska, E., Lemanska, I., Szombara, E., Nowecki, Z.I.

Volltext

HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch von Dubianski, R., Sarnowska, E., Leszczynski, M., Kubala, S., Olszewski, W., Rusetska, N., Jagiello-Gruszfeld, A.I., Konopinski, R., Sarnowski, T.J., Siedlecki, J.A., Nowecki, Z.I.

Volltext

The role of SWI/SNF chromatin remodelling complex ATPase subunit - BRM in TNBC von Jancewicz, I., Rusetska, N., Armatowska, A., Stachowiak, M., Pogoda, K., Niwińska, A., Olszewski, W., Nowecki, Z.I., Sarnowski, T.J., Sarnowska, E., Siedlecki, J.A.

Volltext

Subcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis von Kümmel, S., Tondini, C.A., Abraham, J., Nowecki, Z.I., Itrych, B., Hitre, E., Karaszewska, B., Juarez, A., Morales-Vásquez, F., Pérez García, J.M., Cardona-Huerta, S., Heinzmann, D., He, J., Duc, A.N., Crepelle-Fléchais, A., Martín, M.

Volltext

9302 Excellent long-term survival of patients with minimal sentinel node tumor burden (<0.1 mm) according to Rotterdam Criteria: a study of the EORTC melanoma group von van Akkooi, A.C.J, Rutkowski, P, van der Ploeg, I.M, Voit, C, Robert, C, Hoekstra, H.J, Nieweg, O.E, Nowecki, Z.I, Spatz, A, Eggermont, A.M.M

Volltext

7006 ORAL Prognosis depends on micro-anatomic patterns of melanoma micrometastases within the sentinel node (SN). A multicenter study in 388 SN positive patients von van Akkooi, A.C.J, Nowecki, Z.I, Voit, C, Schaefer, G, Michej, W, Kliffen, M, Schmitz, P.I.M, Ruka, W, Eggermont, A.M.M

Volltext

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperati... von Nowecki, Z.I., Rutkowski, P., Kulik, J., Siedlecki, J.A., Ruka, W.

Volltext

Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection von Rutkowski, P, Debiec-Rychter, Maria, Nowecki, Z.I, Michej, W, Symonides, M, Ptaszynski, K, Ruka, W

Volltext

In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection von Rutkowski, P., Nowecki, Z.I., Zurawski, Z., Dziewirski, W., Nasierowska-Guttmejer, A., Świtaj, T., Ruka, W.

Volltext

Lymph node status and survival in cutaneous malignant melanoma—sentinel lymph node biopsy impact von Rutkowski, P, Nowecki, Z.I, Nasierowska-Guttmejer, A, Ruka, W

Volltext